About Us

We believe our passion can lead to real change for patients, and our approach goes beyond what’s expected

Committed to improving the lives of patients suffering from acid-related gastrointestinal disorders.

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases. We have licensed the exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB) which the company has been developing for the treatment of certain GI disorders.

We completed Phase 3 clinical trials for the treatment of Erosive GERD, Non-Erosive GERD, and H. pylori infection, respectfully, and plan to soon initiate an additional Phase 3 trial investigating a novel “As Needed” dosing regimen for patients with Non-Erosive GERD.

Management Team

Meet our team of experts working to usher in a new era of treatment for patients with acid-related disorders.

Headshot of Terrie Curran

Terrie Curran

President & Chief Executive Officer

Headshot of Azmi Nabulsi, M.D., M.P.H.

Azmi Nabulsi, M.D., M.P.H.

Chief Operating Officer

Headshot of Martin Gilligan

Martin Gilligan

Chief Commercial Officer

Tom Harris headshot

Tom Harris

Chief Development Sciences Officer

Headshot of Molly Henderson

Molly Henderson

Chief Financial & Business Officer

Headshot of Eckhard Leifke, M.D., Ph.D.

Eckhard Leifke, M.D.

Chief Medical Officer

Headshot of Larry Miller, J.D.

Larry Miller, J.D.

General Counsel

Board of Directors

Headshot of Terrie Curran

Terrie Curran

President & Chief Executive Officer, Phathom

Headshot of David Socks

David Socks

Chief Financial Officer & Chief Business Officer, HilleVax, Inc.

Headshot of Michael Cola

Michael Cola

Former Chief Executive Officer, Avalo Therapeutics, Inc.

Headshot of Frank Karbe

Frank Karbe

President & Chief Executive Officer, Better Therapeutics, Inc.

Headshot of Heidi Kunz

Heidi Kunz

Former Chief Financial Officer, Blue Shield California

Headshot of Asit Parikh, M.D., Ph.D.

Asit Parikh, M.D., Ph.D.

President & Chief Executive Officer, MOMA Therapeutics

Headshot of Mark Stenhouse

Mark Stenhouse

Chief Operating Officer, Prometheus Biosciences

Headshot of James Topper, M.D., Ph.D.

James Topper, M.D., Ph.D.

Managing Partner, Frazier Life Sciences

Phathom Co-Founders

Headshot of Tadataka (Tachi) Yamada, M.D.

Tadataka (Tachi) Yamada, M.D.

Co-Founder and Late Chairman, Phathom

Headshot of David Socks

David Socks

Co-Founder, Phathom

Headshot of Azmi Nabulsi, M.D., M.P.H.

Azmi Nabulsi, M.D., M.P.H.

Co-Founder, Phathom

Headshot of Aditya Kohli, Ph.D.

Aditya Kohli, Ph.D.

Co-Founder, Phathom